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Abstract Previously, we clarified the surface antigen
profiles of hepatic progenitor cells (HPCs) in fetal liver
tissue as the CD49f
+CD45
−Thy1
− cell fraction. However,
these cells were a heterogeneous cell population containing
various stages of differentiation. This study aimed to detect
more immature HPCs, using a novel surface antigen, gp38.
After the collagenase digestion of fetal livers harvested
from E13.5 to E18.5 fetal mice, HPCs were obtained and
divided into two subpopulations using flow cytometry:
gp38-positive HPCs, and gp38-negative HPCs. Both types
of HPCs were characterized by immunocytochemistry and
RT-PCR. The proliferative activity was compared by BrdU
incorporation and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphe-
nyltetrazolium bromide (MTS) assay. Furthermore, the
comprehensive gene expression was investigated by DNA
microarray. Both types of HPCs expressed alpha-fetoprotein.
However, the gp38-positive HPCs derived from E13.5 fetal
livers did not express albumin or cytokeratin 19, while
the gp38-negative HPCs did. DNA microarray revealed
that some genes related to the Wnt signal pathway were
up-regulated in the gp38-positive HPCs. Furthermore,
Wnt3a had a proliferative effect on the gp38-positive
HPCs. In conclusion, the gp38-positive HPCs derived
from fetal liver tissue until E13.5 could therefore be
candidates for hepatic stem cells in the fetal liver.
Keywords Hepatic stem cell.Hepatic progenitor cell.
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Introduction
Hepatic stem cells and hepatic progenitor cells (HPCs) are a
potential cell source of cell therapy for liver diseases
because of their highly proliferative activities (Kubota and
Reid 2000; Crosby et al. 2001; Sandhu et al. 2001; Suzuki
et al. 2002; Yin et al. 2002; Oertel et al. 2003; Petersen et
al. 2003; Tanimizu et al. 2003). They are supposed to have
bipotency to differentiate into hepatocytes and cholangio-
cytes. However, the accurate identification of hepatic stem
cells, and also the relationship between hepatic stem cells
and HPCs has still remained to be elucidated.
Previously, the surface antigen profiles of HPCs residing
in the E13.5 fetal murine liver were clarified (Yasuchika et al.




cells (CD49f-positive HPCs) using flow cytometry (Hoppo
et al. 2004; Ishii et al. 2005). These cells showed a
heterogeneous staining pattern of albumin and cytokeratin
19 (CK19), thus suggesting that they contained multiple
populations of HPCs at various stages of differentiation
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DOI 10.1007/s11626-010-9354-7(Hoppo, et al. 2004). A DNA subtraction analysis was
conducted to identify the surface antigen that was specific for
hepatic stem/progenitor cells and focused on gp38 (also
known as podoplanin) because it is expressed in fetal livers
but not in adult livers. Gp38 is a mucin-type transmenbrane
glycoprotein and is well established as a lymphatic marker
because of its specific expression in the endothelium of
lymphatic capillaries but not in the blood vessel endothelium
(Breiteneder-Geleff et al. 1999). Mesenchymal cells residing




cells (Thy1-positive mesenchymal cells) can be divided into












mesenchymal cells) played an inhibitory role on the
maturation of HPCs. In other words, the gp38-negative
mesenchymal cells maintain the immature, proliferative state
of HPCs.
This study aimed to further fractionate the HPCs using
gp38 in order to identify more immature HPCs, which could
beputativehepaticstemcells.Inaddition,thisstudyattempted
to elucidate the mechanism that underlies the maintenance of
the undifferentiated state of immature HPCs.
Materials and Methods
Animals. C57BL/6 J mice were obtained from SLC
(Hamamatsu, Japan). The animals were maintained at a
constant temperature of 18°C to 20°C and in a 12-h light/
12-h dark cycle. All experimental procedures utilizing
animals were performed in accordance with the Animal
Protection Guidelines of Kyoto University.
Isolation and culture of fetal liver cells. Fetal livers were
obtained from embryonic d 11.5 (E11.5), E13.5, E15.5 and
E18.5 fetal mice respectively and HPCs were enriched by
the formation of cell aggregates. The isolation and culture
of the cell aggregates was performed as described previ-
ously (Yasuchika et al. 2002; Hoppo et al. 2004). Briefly,
fetal liver cells digested by 0.5% collagenase were cultured
on Petri dishes, allowing cell aggregation. The cell
aggregates were inoculated onto collagen type I-coated
plates, followed by dissociation of the adherent cells using
0.25% trypsin-ethylenediaminetetraacetic acid solution
(Sigma Chemical Co., Ltd., St. Louis, MO) after 24 h of
culture. These cells were analyzed using FACSCalibur (BD
Biosciences, Franklin Lakes, NJ).
Flow cytometry and cell sorting. Cultured fetal liver cells
were sorted out by phycoerthrin (PE)-conjugated anti-
CD45, PE-conjugated anti-CD49f and fluorescein-
conjugated anti-Thy1 antibodies using a flow cytometer
(FACSVantage SE, BD Biosciences) as previously
described (Hoppo et al. 2004; Ishii et al. 2005). Rat anti-
mouse gp38 monoclonal antibody (8F11) was labeled by
allophycocyanin according to the manufacturer’si n s t r u c t i o n s
(Kato et al. 2004). Dissociated cells were incubated with
anti-gp38 diluted at 1:100 at 4°C for 30 min followed by










− cells (gp38-negative HPCs) were
cultured on collagen type I-coated 24-well plates at a density
of 2×10
4 cells/well in Dulbecco’sm o d i f i e dE a g l e ’sm e d i u m
(GIBCO-BRL, Grand Island, NY) supplemented with 10%
fetal calf serum, 20 mmol/l HEPES, 25 mmol/l NaHCO3,
0.5 mg/l insulin, 1×10
−7 mol/l dexamethasone (Wako,
Osaka, Japan), 10 mmol/l nicotinamide (Wako), 2 mmol/l
L-ascorbic acid phosphate (Wako), penicillin/streptomycin
and 20 ng/ml hepatocyte growth factor (R&D Systems,
Minneapolis, MN).
Immunocytochemistry of cultured cells. After washing
t w i c ei nP B S ,t h ec u l t u r e dc e l l sw e r ef i x e di n4 %
paraformaldehyde (PFA) for 15 min at room temperature.
Immunocytochemistry for alphãfetoprotein (AFP), albu-
min, and CK19 was performed as previously described
(Yasuchika et al. 2002; Hoppo et al. 2004; Ishii et al.
2007;K a m oe ta l .2007). To perform immunostaining for
gp38, anti-mouse gp38 antibody (8.1.1: the hamster
monoclonal antibody specific for gp38 was a kind gift of
Dr. Andrew G. Farr, University of Washington School of
Medicine, Seattle, WA)was used as a first antibody at a
dilution of 1:10. Alexa 590-goat anti-hamster IgG
(Molecular Probes, Inc., Eugene, OR) was used as a





α-smooth muscle actin 5′-CTATTCAGGCTGTGCTGTTCC 5′-GGACCTCTTCTCGATGCTGA
β-actin 5′-TCCTATGTGGGTGACGAGGC 5′-TACATGGCTGGGGTGTTGAA
Table 1. PCR primer sequences
46 KONISHI ET AL.second antibody at the dilution of 1:800. DAPI staining
was performed according to the standard protocol. In
order to stain the isolated cells just after the cell sorting,
they were attached to slides by centrifugation at 1,000×g
and then were fixed by 4% PFA. Thereafter, immunostain-
ing was performed as described above. In every experi-
ment, the expression ratio of AFP and albumin and CK19
were calculated in three independent fields and evaluated
as the means±standard deviation (SD).
Reverse transcription polymerase chain reaction (RT-
PCR). Total RNA was extracted from both the gp38-
positive HPCs and gp38-negative HPCs derived from E11.5,
E13.5, and E18.5 fetal mice livers using an RNeasy Mini kit
(Qiagen,Chatsworth,CA)andtreatedwithRNase-freeDNase
(Qiagen). Total RNA (0.065 μg) was reverse-transcribed into
cDNA with oligo (dT) 12-18 primer (Invitrogen, Carlsbad,
CA) using an Omniscript RT kit (Qiagen). PCR utilized Ex
Taq polymerase (Takara Bio Inc., Otsu, Japan) according to
the manufacturer’s instructions. The primers used for ampli-
fication are listed in Table 1.
DNA microarray analysis. Total RNA was extracted from
the gp38-positive HPCs and gp38-negative HPCs immedi-
ately after cell sorting using an RNeasy Mini Kit (Qiagen)
as described above. A microarray analysis was performed
according to the standard protocol (Affymetrix GeneChip
Manual, Affymetrix, Santa Clara, CA). Briefly, cRNA was
synthesized from 100 ng total RNA and then biotinylated
using the two-cycle target labeling method. Fifteen μg
cRNA were hybridized to a Mouse Genome 430 2.0 Array
(Affymetrix). The array images were scanned using a
GeneChip Scanner 3,000 (Affymetrix), after amplification
and detection of the hybridized signals through the
streptavidin-conjugated phycoerythrin fluorescence. The
obtained data were analyzed using the GeneChip Operating
Software program (Affymetrix). After experimental normal-
ization, data mining was performed using the GeneSpring
system (Agilent Technologies, Palo Alto, CA). A greater than
a 2-fold expression level was assumed to be significant.
Cell proliferation assay. In bromodeoxyuridine (BrdU)
incorporation assay, cultured cells were incubated with
10 μM BrdU for 24 h and then incubated with 2 N HCl for
1 h at 37°C. Incorporated BrdU was detected by immuno-
cytochemistry using an anti-BrdU antibody conjugated to
horseradish peroxidase (Dako, Glostrup, Denmark). The
peroxidase activity was determined by ENVISION KIT/





Table 2. Quantitative PCR
primer sequences
Figure 1. Flow cytometric and
RT-PCR analyses of fetal mouse
liver cells. (A)F l o wc y t o m e t r i c
fractionation of the cell aggregates
derived from E13.5 fetal livers
using anti-CD45, CD49f, and
Thy1 antibodies. The cell aggre-

















cells). (B) The CD49f-positive
HPCs were further separated into
two fractions using anti-gp38
antibodies. (C)A nR T - P C R
analysis of the gp38-positive
HPCs (left) and the gp38-negative
HPCs (right).
A NOVEL MARKER FOR HEPATIC STEM CELLS, GP38 47HRP (DAB) (Dako, Glostrup Denmark) according to the
manufacturer’s instructions. In every experiment, the ratio
of BrdU incorporating cells was calculated in three
independent fields and evaluated as the means±SD.
The cell numbers of the gp38-positive and gp38-
negative cells were evaluated at 2 d and 10 d after cell
sorting by the MTS assay (Cell Titer 96 Aqueous One
Solution Reagent, Promega, Madison, WI), which was
performed according to the manufacturer’s protocol. After
2 h of incubation, the absorbance value at 490 nm was
measured using a plate reader, and the doubling time of
both the gp38-positive and gp38-negative HPCs was
calculated in the presence or absence of the Wnt ligands.
Quantitative PCR. For quantitative PCR, total RNA was
reverse-transcribed into cDNA using random primers
(Invitrogen). Quantitative PCR was performed with 7,500
Fast Real-Time PCR System (Applied Biosystems, Foster
City, CA) using SYBR Green PCR Master Mix (Applied
Biosystems) according to the manufacturer’s protocol. The
quantified values of each gene were normalized against
GAPDH expression using the comparative threshold cycle
method. The primers used are listed in Table 2.
Statistical analysis. Statistical analysis was performed
using Student’s t test. P<0.05 was identified to be
statistically significant.
Results
Characterization of gp38-positive and gp38-negative
HPCs. Flow cytometric analyses using anti-CD45,
CD49f, Thy1, and gp38 antibodies showed that the fetal
liver cells obtained from E13.5 fetal mouse liver tissues












+ fraction (G3: Thy1-positive mesen-
chymal cells) as described in our previous reports (Hoppo




− cells (CD49f-positive HPCs) were










cells (gp38-negative HPCs; Fig. 1B). The fraction of 98.3±
0.3% of the CD49f-positive HPCs was negative for gp38,
however; approximately 1.7±0.3% of the CD49f-positive
HPCs expressed gp38. RT-PCR analyses revealed that AFP
was expressed in both the gp38-positive and gp38-negative
HPCs. Although the gp38-negative HPCs expressed both
albumin (a hepatocyte marker) and CK19 (a cholangiocyte
marker), the gp38-positive HPCs expressed neither of them
(Fig. 1C). Immunocytological assays revealed that the sorted
gp38-positive HPCs were positive for gp38 and negative for
Thy1 (Fig. 2A, C), whereas the sorted gp38-negative HPCs
were negative for both gp38 and Thy1 (Fig. 2B, D). With
regard to the expression of differentiation markers of hepatic
endoderm, AFP, albumin, and CK19 were detected as much
as 100±0%, 4.0±6.9% and 5.7±4.9%, respectively in the
gp38-positive HPCs (Fig. 2E, G, I). On the other hand, the
Figure 2. Immunocytological analyses of the gp38-positive (left) and
gp38-negative HPCs (right) of E13.5. Each of them was stained for
gp38 (A, B) Thy1 (C, D), AFP (E, F), and albumin with CK19 (G, H).
Blue fluorescence represents the staining of DAPI. The graph
represents the proportion of AFP-, albumin-, and CK19-positive cells
in both the gp38-positive and gp38-negative HPC fractions (E13.5)
(I). Scale bars indicate 100 μm.
48 KONISHI ET AL.gp38-negative HPCs expressed AFP, albumin, and CK19 as
much as 94.0±7.0%, 71.3±17.6% and 51.7±4.7%, respec-
tively (Fig. 2F, H, I). These findings suggested that a majority
of the gp38-positive HPCs had undergone neither hepatocyte
nor cholangiocyte differentiation in comparison to the
gp38-negative HPCs.
MTS assay revealed that the doubling time of the
gp38-positive HPCs tended to be shorter than that of the
gp38-negative HPCs (Table 3). Furthermore, 84.7±3.5%
of the gp38-positive HPCs incorporated BrdU (Fig. 3A, C),
whereas only 18.1±5.4% of the gp38-negative HPCs did
(Fig. 3B, C). These findings suggested that the gp38-positive
HPCs had a higher proliferative activity than the gp38-
negative HPCs.
Time course analysis of the gp38-positive HPCs. In order
to examine the behavior of both types of HPCs in the
different embryonic stage livers, the proportion of the gp38-
positive HPCs were measured at E11.5, E13.5, E15.5, and
E18.5, respectively. Although the proportion of the gp38-
positive cells decreased as the fetal liver developed until
E13.5, it increased abruptly at E18.5 (Fig. 4A). Immuno-
cytological staining was performed to characterize the
gp38-positive and gp38-negative HPCs in the E18.5 fetal
liver. Although a large number of the gp38-positive HPCs
were still positive for AFP, namely as much as 82.1±13.9%
(Fig. 4B, F), the expression of albumin and also CK19 were
up-regulated to 25.9±21.4% and 79.2±7.6%, respectively
(Fig. 4D, F). On the other hand, the gp38-negative HPCs
nolongerexpressed AFP asmuchas0.05±0.1%(Fig. 4C, F),
whereas the expression of albumin and CK19 were also
increased up to 66.3±13.0% and 98.7±0.9%, respectively
(Fig. 4E, F). These findings suggested that the gp38-positive
HPCs at E18.5 were different from those at E13.5.
DNA microarray analysis of the gp38-positive and gp38-
negative HPCs. Inorder toclarify the molecular mechanisms
underlying the undifferentiated state of the gp38-positive
HPCs, comprehensive gene expressions were compared
among the gp38-positive and gp38-negative HPCs derived
from E13.5 fetal liver using DNA microarray. The microarray
analyses revealed that the Wnt4, 5a, 5b, 9a, 11, frizzled
homolog (Fzd) 1, 2, 8, and 10 genes were expressed
preferentially in the gp38-positive HPCs, whereas the Foxa2,
Figure 3. BrdU uptake of the
gp38-positive and gp38-
negative HPCs. The cells with
brown stained nucleus represent
BrdU incorporated cells in the
gp38-positive HPCs (A), and
those of the gp38-negative
HPCs (B). The graph represents
the proportion of the uptake of
BrdU (C,* ;P=0.001, tested by
Student’s t test). Scale bars
indicate 100 μm.
Table 3. Doubling time of the gp38-positive and gp38-negative
HPCs in the presence or absence of Wnt signaling stimulation
Without Wnt3a With Wnt3a P
gp38-positve HPC 172.9±109 57.1±10.8 0.057
gp38-negative HPC 814.2±566.8 520.3±251.6 0.089
P 0.063 0.016
The number represents the doubling time (h, the mean±SD; n=4)
A NOVEL MARKER FOR HEPATIC STEM CELLS, GP38 49Hex and c-Met genes were expressed preferentially in the
gp38-negative HPCs. It was therefore suggested that some
genes related to the Wnt signal pathway were up-regulated in
the gp38-positive HPCs of E13.5 fetal mice. There was,
however,nosignificant difference inothergenes relatedtothe
sonic hedgehog and notch signal pathways (Fig. 5).
The effects of the Wnt signal pathway on the cell
proliferation and differentiation of HPCs. MTS assay
revealed that the doubling time of the gp38-positive HPCs
tended to become shorter in the presence of Wnt3a.
Furthermore, the doubling time of the gp38-positive HPCs
were significantly shorter than that of the gp38-negative
HPCs in the presence of Wnt3a. On the other hand, Wnt3a
had no obvious effects on the cell proliferation activity of
the gp38-negative HPCs (Table 3). To investigate the effect
of Wnt3a on the gene expression of the gp38-positive
HPCs, quantitative RT-PCR was performed. The AFP,
albumin, and CK19 gene expressions of the gp38-positive
HPCs cultured in the presence of Wnt3a were examined in
comparison to that in the absence of Wnt3a. No significant
difference was observed in the gene expression of AFP
(P=0.089), albumin (P=0.071) and CK19 (P=1.000;
Fig. 6). These findings suggested that the activation of the
Wnt signal pathway by Wnt3a could tend to stimulate the
proliferation without any effects of the differentiation on
the gp38-positive HPCs.
Discussion
The previous analyses of the developmental biology of liver
tissue revealed that hepatoblasts expressing AFP differen-
tiated from anterior foregut endoderm at E8.5 with
formation of a liver bud (Shiojiri 1981; Belayew and
Tilghman 1982; Gualdi et al. 1996). One day after the AFP
expression, albumin and CK19 are expressed in hepatoblasts.
As fetal livers develop, the AFP and CK19 expressions
decrease in hepatoblasts committed to hepatic differentiation,
and albumin expression is up-regulated. On the other hand,
the AFP and albumin expressions are down-regulated in the
hepatoblasts committed to cholangiocyte differentiation,
whereas the CK19 expression increases. Hepatoblasts are
supposed to have the ability to differentiate into both
hepatocytes and cholangiocytes (Shiojiri 1981;C a s c i oa n d
Zaret 1991; Smas and Sul 1993; Shiojiri et al. 2001).
Therefore, hepatoblasts correspond to hepatic progenitor
cells.
The CD49f-positive HPCs could be separated by the
expression of the surface antigen gp38. Both the gp38-
positive and the gp38-negative HPCs derived from E13.5
fetal liver expressed the fetal hepatic marker, AFP.
Figure 4. The time course analyses of the gp38-positive and gp38-
negative HPCs. (A) The graph indicates the proportion of the gp38-
positive and gp38-negative HPCs among the total HPCs. (B–E)
Immunocytochemistry of the gp38-positive HPCs (B, D) and the
gp38-negative HPCs (C, E) (E18.5). Red fluorescence represents AFP
(B, C), green fluorescence represents albumin (D, E), and red
fluorescence represents CK19 (D, E). Blue fluorescence represents
the nucleus stained by DAPI. Scale bars indicate 100 μm. (F) The
graph represents the proportion of AFP-, albumin-, and CK19-positive
cells in both the gp38-positive and gp38-negative HPC fractions
(E18.5).
50 KONISHI ET AL.However, the gp38-positive HPCs did not express either of
the hepatocyte marker, albumin or the cholangiocyte-
marker, CK19, while the gp38-negative HPCs did. Further-
more, the gp38-positive HPCs had higher rates of the BrdU
incorporation than the gp38-negative HPCs did, thus
indicating the gp38-positive HPCs to have increased
proliferative activity in comparison to the gp38-negative
HPCs. Therefore, the gp38-positve HPCs appeared to be
more immature than the gp38-negative HPCs. Single cell
culture assays were tried in order to investigate the self-
renewal ability and the multipotency of the gp38-positive
HPCs, which were required to define them as hepatic stem
cells.However,theseassaysweretechnicallydifficultbecause
of a significant deterioration in the cell viability after single
cell sorting. This was considered to be caused by the
inevitable mechanical stress of cell sorting or to indicate their
own characteristics after the loss of cell-to-cell contact, which
was similar to the characteristics of human embryonic stem
cells (Suemori et al. 2006; Ishii et al. 2008).
The proportion of the gp38-positive HPCs decreased
gradually until E13.5, thus suggesting the gp38-positive
cells to differentiate into the gp38-negative HPCs as fetal
livers developed. At E18.5, however, the proportion of the
gp38-positive HPCs increased abruptly. The large number
Figure 5. Microarray analyses
comparing the gene expression
between the gp38-positive and
gp38-negative HPCs. The black
bars indicate the gene expres-
sion of the gp38-positive HPCs
and the white bars show those
of the gp38-negative HPCs. Dhh
desert hedgehog, Shh sonic
hedgehog, Ptch patched homo-




Figure 6. Quantitative PCR analyses were performed to examine the
mRNA expression of AFP and albumin and CK19 in the gp38-
positive HPCs cultured in the presence or absence of Wnt3a. The
relative mRNA expressions of AFP and albumin and CK19 were
normalized based on that of GAPDH. These results are expressed as
the means±SD from triplicate assays.
A NOVEL MARKER FOR HEPATIC STEM CELLS, GP38 51of the gp38-positive HPCs (79.2±7.6%) at E18.5 expressed
CK19, which indicated the differentiation to cholangio-
cytes, unlike those at E13.5. These findings suggested the
characteristics of the gp38-positiveHPCs derived from E18.5
fetal liver were different from those of E13.5. Gp38 is
expressed in various cells and tissues of normal human adults,
including the kidney podocytes, skeletal muscle, placenta,
lung, and heart.In addition, gp38 isup-regulated in squamous
cell carcinoma, mesothelioma, and tumors of central nerve
system (Wicki and Christofori 2007). Furthermore, some
studies reported that bile duct epithelial cells expressed gp38
during the late embryonic to neonatal stage (Schacht et al.
2005). Therefore, the gp38 might be a marker for more
immature hepatic progenitor cells only at earlier develop-
mental stages, whereas it could be a marker for cholangio-
cytes at late developmental stage. In other words, gp38 might
be a stage-specific marker of immature HPCs.
The Wnt/β-catenin signaling pathway contributes the
maintenance of other stem cells such as hematopoietic stem
cells and neural stem cells, and also is involved in
hepatocyte proliferation and in hepatic regeneration
(Monga et al. 2001, 2003; Reya et al. 2003; Willert et al.
2003; Micsenyi et al. 2004). In the present study, DNA
microarray analyses between the gp38-positive and gp38-
negative HPCs revealed that some genes related to the Wnt
signaling pathway were up-regulated in the gp38-positive
HPCs. The activation of Wnt signal pathway in the gp38-
positive HPCs was confirmed by immunocytochemistry of
β-catenin, thus showing the nuclear accumulation of β-
catenin after stimulation by Wnt ligands (data not shown).
Although there was no obvious difference in the proliferative
activity of the gp38-positive cells in the presence of Wnt5a,
5b, 7a (data not shown), a progressive tendency was observed
in the gp38-positive cells after the administration of Wnt3a.
The MTS assay and quantitativeRT-PCRrevealedthatWnt3a
tended to induce cell proliferation of the gp38-positive HPCs,
whereas it played no significant role on their differentiation.
On the other hand, Wnt5a, 5b, 7a, which were expressed
preferentially in the gp38-positive HPCs, had no obvious
effectontheirproliferationorthegeneexpressionofthegp38-






derived from the fetal murine livers accelerated the cell
proliferation of the HPCs by production of some humoral
factors (Kamo et al. 2007). This suggests that some
soluble stimulators secreted by these mesenchymal cells
were necessary to maintain the undifferentiated state of
HPCs. Wnt3a, which was shown to have a positive effect
on cell proliferation of the gp38-positive HPCs, would be
one of the candidates for those factors. However, some
other factors would be necessary in combination with
Wnt3a.
Conclusions
The gp38-positive HPCs possessed more immature charac-
teristics of HPCs, thus suggesting they could be candidates
for hepatic stem cells. Furthermore, the activation of the
Wnt signal pathway tended to maintain the undifferentiated
state of the HPCs. These findings are expected to contribute
to the elucidation of the molecular mechanisms that
underlie hepatic development in the future.
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